Barely Significant
← all excerpts

Synthesis, molecular docking, and in vivo antidiabetic evaluation of new benzylidene-2,4-thiazolidinediones as partial PPAR-γ agonists.

Sci Rep · 2023 · PMC10645977 · PMID 37963936

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantp < 0.0001actually significant
Pairwise comparison between groups at each time revealed that all the test compounds induced a highly significant ( p < 0.0001) reduction in BGL comparable with the standard drug rosiglitazone.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.